METASTATIC NEUROENDOCRINE CARCINOMA
Clinical trials for METASTATIC NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough cancers
Disease control OngoingThis early-phase trial tests a new drug called BAY 1895344 combined with standard chemotherapy (irinotecan or topotecan) in people with advanced solid tumors, especially small cell lung cancer, poorly differentiated neuroendocrine cancer, and pancreatic cancer. The goal is to fin…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Triple-Drug cocktail shows promise against rare neuroendocrine tumors
Disease control OngoingThis phase 2 trial is testing a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—in 17 people with advanced neuroendocrine cancer that has spread. The goal is to see if the combination can shrink tumors or stop them from growing. Cabozantinib blocks enzymes that…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo attack on stubborn cancers shows promise in early trial
Disease control OngoingThis phase II trial tests whether combining the immunotherapy drug nivolumab with the chemotherapy drug temozolomide can shrink tumors in people with small-cell lung cancer that has returned or not responded to treatment, or advanced neuroendocrine tumors. About 55 participants w…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC